Daily Briefing

What Changed

Sanofi's SWEL proof point shifts the deployment question from whether cloud-hosted AI agents can compress discovery cycles to how fast R&D teams can migrate internal pipelines onto agent-orchestrated AWS services to capture tenfold workflow-launch acceleration [1].

Industry & Products | Sanofi’s SWEL on AWS enables AI agents to design molecules and accelerate discovery. Sanofi’s SWEL, built on AWS Bedrock AgentCore and HealthOmics, lets AI agents design molecules, plan syntheses, run assays and analyze data with shared context, cutting the molecules requiring wet‑lab validation by 50% and increasing AI workflow deployment speed tenfold, which allows two to three times more in‑silico projects in the same period [1].

Clinical Practice | Epic’s Ergo Visit AI tool summarizes patient data to guide outpatient visits. Epic’s new AI capability pulls information from the EHR to create visit‑level summaries and suggests next steps, aiming to streamline outpatient workflows by reducing time spent on data gathering during patient encounters [2].

Medical Imaging | Centralized NLP‑EHR surveillance tracks abdominal aortic aneurysm patients. The STAIR program combined internally developed NLP on radiology reports with structured EHR queries, clinician referrals and automated lost‑to‑follow‑up detection to identify, track and manage AAA cases across a large integrated health system from December 2022 to April 2026, demonstrating how automated surveillance can improve longitudinal monitoring of incidental findings [3].

Clinical Practice | Logistic regression model predicts osteoporosis in primary Sjögren’s syndrome. A model using sex, age, glucocorticoid use, EULAR‑SSDAI, vitamin D, P1NP and β‑CTX achieved an AUC of 0.787 in external validation at Shanghai Seventh People’s Hospital, offering a disease‑specific tool for osteoporosis risk assessment in this patient population [4].